Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 11.70
+0.30 (2.63%)
At close: Feb 5, 2026
STO:MAGLE Revenue
Magle Chemoswed Holding AB had revenue of 74.91M SEK in the quarter ending September 30, 2025, with 12.24% growth. This brings the company's revenue in the last twelve months to 300.49M, up 43.63% year-over-year. In the year 2024, Magle Chemoswed Holding AB had annual revenue of 240.57M with 40.27% growth.
Revenue (ttm)
300.49M
Revenue Growth
+43.63%
P/S Ratio
0.80
Revenue / Employee
2.09M
Employees
144
Market Cap
241.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 240.57M | 69.07M | 40.27% |
| Dec 31, 2023 | 171.50M | 23.51M | 15.89% |
| Dec 31, 2022 | 147.98M | 15.84M | 11.98% |
| Dec 31, 2021 | 132.15M | -10.19M | -7.16% |
| Dec 31, 2020 | 142.34M | 10.55M | 8.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xbrane Biopharma AB | 259.70M |
| Bio-Works Technologies AB | 46.43M |
| Intervacc AB | 21.09M |
| Elicera Therapeutics AB | 13.70M |
| NextCell Pharma AB | 11.06M |
| Medivir AB | 3.88M |
| Xintela AB | 2.96M |
| Lipum AB | 398.00K |